Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

October 01, 2014; Volume 42,Issue 10

Perspective

  • You have access
    Lost in Centrifugation: Accounting for Transporter Protein Losses in Quantitative Targeted Absolute Proteomics
    Matthew D Harwood, Matthew R Russell, Sibylle Neuhoff, Geoffrey Warhurst and Amin Rostami-Hodjegan
    Drug Metabolism and Disposition October 2014, 42 (10) 1766-1772; DOI: https://doi.org/10.1124/dmd.114.058446

Short Communication

  • You have access
    Brain Penetration of WEB 2086 (Apafant) and Dantrolene in Mdr1a (P-Glycoprotein) and Bcrp Knockout Rats
    Holger Fuchs, Wataru Kishimoto, Dietmar Gansser, Paul Tanswell and Naoki Ishiguro
    Drug Metabolism and Disposition October 2014, 42 (10) 1761-1765; DOI: https://doi.org/10.1124/dmd.114.058545

Articles

  • You have access
    Toward a Unified Model of Passive Drug Permeation II: The Physiochemical Determinants of Unbound Tissue Distribution with Applications to the Design of Hepatoselective Glucokinase Activators
    Avijit Ghosh, Tristan S. Maurer, John Litchfield, Manthema V. Varma, Charles Rotter, Renato Scialis, Bo Feng, Meihua Tu, Cris R. W. Guimaraes and Dennis O. Scott
    Drug Metabolism and Disposition October 2014, 42 (10) 1599-1610; DOI: https://doi.org/10.1124/dmd.114.058032
  • You have access
    The Effects of Milk Thistle (Silybum marianum) on Human Cytochrome P450 Activity
    Marina Kawaguchi-Suzuki, Reginald F. Frye, Hao-Jie Zhu, Bryan J. Brinda, Kenneth D. Chavin, Hilary J. Bernstein and John S. Markowitz
    Drug Metabolism and Disposition October 2014, 42 (10) 1611-1616; DOI: https://doi.org/10.1124/dmd.114.057232
  • You have access
    Differential Effect of Liver Cirrhosis on the Pregnane X Receptor–Mediated Induction of CYP3A1 and 3A2 in the Rat
    Sara De Martin, Daniela Gabbia, Giovanna Albertin, Maria Martina Sfriso, Claudia Mescoli, Laura Albertoni, Giovanna Paliuri, Sergio Bova and Pietro Palatini
    Drug Metabolism and Disposition October 2014, 42 (10) 1617-1626; DOI: https://doi.org/10.1124/dmd.114.058511
  • You have access
    Biosynthesis of Drug Metabolites and Quantitation Using NMR Spectroscopy for Use in Pharmacologic and Drug Metabolism Studies
    Gregory S. Walker, Jonathan N. Bauman, Tim F. Ryder, Evan B. Smith, Douglas K. Spracklin and R. Scott Obach
    Drug Metabolism and Disposition October 2014, 42 (10) 1627-1639; DOI: https://doi.org/10.1124/dmd.114.059204
  • You have access
    Assessment of Intestinal Availability (FG) of Substrate Drugs of Cytochrome P450s by Analyzing Changes in Pharmacokinetic Properties Caused by Drug–Drug Interactions
    Akihiro Hisaka, Mikiko Nakamura, Ayako Tsukihashi, Saori Koh and Hiroshi Suzuki
    Drug Metabolism and Disposition October 2014, 42 (10) 1640-1645; DOI: https://doi.org/10.1124/dmd.114.059147
  • You have access
    Physiologically Based Pharmacokinetic Prediction of Telmisartan in Human
    Rui Li, Avijit Ghosh, Tristan S. Maurer, Emi Kimoto and Hugh A. Barton
    Drug Metabolism and Disposition October 2014, 42 (10) 1646-1655; DOI: https://doi.org/10.1124/dmd.114.058461
  • You have access
    The Janus Kinase 2 Inhibitor Fedratinib Inhibits Thiamine Uptake: A Putative Mechanism for the Onset of Wernicke’s Encephalopathy
    Qiang Zhang, Yan Zhang, Sharon Diamond, Jason Boer, Jennifer J. Harris, Yu Li, Mark Rupar, Elham Behshad, Christine Gardiner, Paul Collier, Phillip Liu, Timothy Burn, Richard Wynn, Gregory Hollis and Swamy Yeleswaram
    Drug Metabolism and Disposition October 2014, 42 (10) 1656-1662; DOI: https://doi.org/10.1124/dmd.114.058883
  • You have access
    Is Nuclear Factor Erythroid 2–Related Factor 2 Responsible for Sex Differences in Susceptibility to Acetaminophen-Induced Hepatotoxicity in Mice?
    Philip R. Rohrer, Swetha Rudraiah, Michael J. Goedken and José E. Manautou
    Drug Metabolism and Disposition October 2014, 42 (10) 1663-1674; DOI: https://doi.org/10.1124/dmd.114.059006
  • You have access
    Identification of Diet-Derived Constituents as Potent Inhibitors of Intestinal Glucuronidation
    Brandon T. Gufford, Gang Chen, Philip Lazarus, Tyler N. Graf, Nicholas H. Oberlies and Mary F. Paine
    Drug Metabolism and Disposition October 2014, 42 (10) 1675-1683; DOI: https://doi.org/10.1124/dmd.114.059451
  • You have access
    Transcriptional Regulation of Human Hydroxysteroid Sulfotransferase SULT2A1 by LXRα
    Zhimin Ou, Mengxi Jiang, Bingfang Hu, Yixian Huang, Meishu Xu, Songrong Ren, Song Li, Suhuan Liu, Wen Xie and Min Huang
    Drug Metabolism and Disposition October 2014, 42 (10) 1684-1689; DOI: https://doi.org/10.1124/dmd.114.058479
  • You have access
    Microbial Metabolites of Omeprazole Activate Murine Aryl Hydrocarbon Receptor In Vitro and In Vivo
    Kazuhiro Shiizaki, Masanobu Kawanishi and Takashi Yagi
    Drug Metabolism and Disposition October 2014, 42 (10) 1690-1697; DOI: https://doi.org/10.1124/dmd.114.058966
  • You have access
    Characterization of the Active Site Properties of CYP4F12
    John Eksterowicz, Dan A. Rock, Brooke M. Rock, Larry C. Wienkers and Robert S. Foti
    Drug Metabolism and Disposition October 2014, 42 (10) 1698-1707; DOI: https://doi.org/10.1124/dmd.114.059626
  • You have access
    Threonine-290 Regulates Nuclear Translocation of the Human Pregnane X Receptor through Its Phosphorylation/Dephosphorylation by Ca2+/Calmodulin-Dependent Protein Kinase II and Protein Phosphatase 1
    Junko Sugatani, Yoshiki Hattori, Yuji Noguchi, Masahiko Yamaguchi, Yasuhiro Yamazaki and Akira Ikari
    Drug Metabolism and Disposition October 2014, 42 (10) 1708-1718; DOI: https://doi.org/10.1124/dmd.114.059139
  • You have access
    Pharmacoproteomics-Based Reconstruction of In Vivo P-Glycoprotein Function at Blood-Brain Barrier and Brain Distribution of Substrate Verapamil in Pentylenetetrazole-Kindled Epilepsy, Spontaneous Epilepsy, and Phenytoin Treatment Models
    Yasuo Uchida, Sumio Ohtsuki and Tetsuya Terasaki
    Drug Metabolism and Disposition October 2014, 42 (10) 1719-1726; DOI: https://doi.org/10.1124/dmd.114.059055
  • You have access
    Cytochrome P450–Mediated Metabolic Activation of Diosbulbin B
    Dongju Lin, Chunyan Li, Ying Peng, Huiyuan Gao and Jiang Zheng
    Drug Metabolism and Disposition October 2014, 42 (10) 1727-1736; DOI: https://doi.org/10.1124/dmd.114.059261
  • You have access
    Metabolism of Diosbulbin B In Vitro and In Vivo in Rats: Formation of Reactive Metabolites and Human Enzymes Involved
    Baohua Yang, Wei Liu, Kaixian Chen, Zhengtao Wang and Changhong Wang
    Drug Metabolism and Disposition October 2014, 42 (10) 1737-1750; DOI: https://doi.org/10.1124/dmd.114.058222
  • You have access
    Cynomolgus Monkey as a Surrogate for Human Aldehyde Oxidase Metabolism of the EGFR Inhibitor BIBX1382
    J. Matthew Hutzler, Matthew A. Cerny, Young-Sun Yang, Constance Asher, Diane Wong, Kosea Frederick and Kyle Gilpin
    Drug Metabolism and Disposition October 2014, 42 (10) 1751-1760; DOI: https://doi.org/10.1124/dmd.114.059030
  • You have access
    Metabolism and Disposition of Bupropion in Pregnant Baboons (Papio cynocephalus)
    Erik Rytting, Xiaoming Wang, Daria I. Vernikovskaya, Ying Zhan, Cassondra Bauer, Susan M. Abdel-Rahman, Mahmoud S. Ahmed and Tatiana N. Nanovskaya
    Drug Metabolism and Disposition October 2014, 42 (10) 1773-1779; DOI: https://doi.org/10.1124/dmd.114.058255
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 42 (10)
Drug Metabolism and Disposition
Vol. 42, Issue 10
1 Oct 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Perspective
  • Short Communication
  • Articles
  • Most Read
Loading
  • Metabolism and Disposition of Volanesorsen across Species
  • Tissue Drug Concentrations: Beyond the Free Drug Hypothesis
  • PBPK Modeling for Clopidogrel and Its Active Metabolite
  • Pharmacokinetics and Disposition of Biologics
  • Physiology of the Neonatal Gastrointestinal System
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics